SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-024363
Filing Date
2024-02-15
Accepted
2024-02-15 08:00:58
Documents
3
Group Members
E.MERCK KGMERCK KGAA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246392d1_sc13ga.htm SC 13G/A 84877
2 EXHIBIT 99.1 tm246392d1_ex99-1.htm EX-99.1 9678
3 EXHIBIT 99.2 tm246392d1_ex99-2.htm EX-99.2 11799
  Complete submission text file 0001104659-24-024363.txt   108063
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Subject) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91803 | Film No.: 24642170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FRANKFURTER STRASSE 250 POSTFACH 64271 DARMSTADT 2M 64293
Business Address FRANKFURTER STRASSE 250 POSTFACH 64271 DARMSTADT 2M 64293 49 6151 72 0
Merck Healthcare KGaA (Filed by) CIK: 0001923120 (see all company filings)

IRS No.: 981634883 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G/A